Download PDF
Thromb Haemost 1977; 38(02): 0407-0419
DOI: 10.1055/s-0038-1651476
Original Article
Schattauer GmbH

Relations between Activation and Inhibition of Fibrinolysis in the Walls of Human Arteries and Veins

Vincent Noordhoek Hegt
1   Gaubius Institute, Health Research Organization TNO, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 03 December 1976

Accepted 20 April 1977

Publication Date:
04 July 2018 (online)

    Permissions and Reprints

Summary

From systematic studies of both the activation and the inhibition of fibrinolysis in human blood vessels, data which provided insight into the fibrinolysis antagonism along and across the human vessel wall were obtained.

The capacity for fibrinolysis initiated by plasminogen activator in sections of human arteries and veins as demonstrated by the fibrin sfide technique differed greatly along and across the vessel walls. Inhibition of plasmin fibrinolysis in these blood vessels as detected by the fibrin slide sandwich technique was present at sites of low fibrinolytic activity, while inhibition was absent in areas showing strong fibrinolysis. Fibrinolysis was related to endothelial cells, while inhibition of fibrinolysis was brought about by smooth muscle cells. The results indicate that differences in endothelial fibrinolysis may be the result of differences in inhibition of fibrinolysis caused by variations in the number of smooth muscle cells present locally. A systemic decrease in endothelial fibrinolysis observed in endotoxin shock, hyaline membrane disease and a Waterhouse-Friderichsen syndrome appeared to be associated with a systemic increase in inhibition of fibrinolysis not related to smooth muscle cells.

 

  • References

  • 1 Aoki N, Von Kaulla K. N. 1971; The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. American Journal of Clinical Pathology 55: 171.
    CrossrefPubMedGoogle Scholar
  • 2 Aoki N. 1974; Preparation of plasminogen activator from vascular trees of human cadavers. Journal of Biochemistry 75: 731.
    PubMedGoogle Scholar
  • 3 Åstedt B, Pandolfi M. 1975. Tissue culture as a method for studying the release of fibrinolytic activators. In: Davidson J. F, Samama M. M, Desnoyers P. C. (eds.): Progress in Chemical Fibrinolysis and Thrombolysis. Vol. I. Raven Press; New York.: 249.
    Google Scholar
  • 4 Barchewitz G, Guilbert A, Laurent G. 1973; Effect fibrinolytique de la benzarone au niveau de la paroi veineuse chez l’homme. Pathologie et Biologie 21: 555.
    PubMedGoogle Scholar
  • 5 Barchewitz G, Guilbert A, Laurent G. 1975. Fibrinolytic activity induced by benzarone in the venous wall of patients with varicose veins. In: von Kaulla K. N, Davidson J. F. (eds.). Synthetic Fibrinolytic Thrombolytic Agents.. C. Thomas, Springfield; Illinois, U.S.A.: 377.
    Google Scholar
  • 6 Benzer H, Blümel G, Piza F. 1966; Experimentelle Untersuchungen zur Biologie der Gefäßwand. Med. Welt 17: 1361.
    PubMedGoogle Scholar
  • 7 Bernik M. B, Kwaan H. C. 1971; Inhibitors of fibrinolysis in human tissues in culture. American Journal of Physiology 221: 916.
    PubMedGoogle Scholar
  • 8 Bleyl U. 1969. Arteriosklerose und Fibrin-inkorporation. Springer Verlag; Berlin, Heidelberg, New York.:
    Google Scholar
  • 9 Glas-Greenwalt P. 1972; Latent and manifest endothelial fibrinolysis. Third Congress on Thrombosis and Haemostasis, Washington 290 (Abstr.).
    PubMedGoogle Scholar
  • 10 Gurewich V, Hyde E, Lipinski B. 1975; The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator derived from cadaver limbs. Blood 46: 555.
    PubMedGoogle Scholar
  • 11 Hüttner I, Jellinek H, Kerényi T. 1968; Fibrin formations in vascular fibrinoid change in experimental hypertension. An electron microscopic study. Experimental and Molecular Pathology 9: 309.
    CrossrefPubMedGoogle Scholar
  • 12 Ishizu H, Nobuhara M, Kiyotani T, Saito S, Takata H, Funatsu Y, Ando K. 1972; Studies on fluidity of blood on the basis of fibrinolysis. Part 9. On plasminogen activator of vascular wall and its release. Japanese Journal of Legal Medicine 26: 262.
    PubMedGoogle Scholar
  • 13 Kaulla K. N. von, Wasantapruek S. 1969; Extraction of plasminogen activator from canine vascular segments in situ. Proceedings of the Society for Experimental Biology and Medicine (New York) 132: 830.
    PubMedGoogle Scholar
  • 14 Kerényi T, Jellinek H. 1972; Fibrin deposition in smooth muscle cells of muscular type small arteries under temporary conditions of hypoxia. Experimental and Molecular Pathology 17: 1.
    CrossrefPubMedGoogle Scholar
  • 15 Kwaan H. C, Silverman S. 1973; Fibrinolytic activity in lesions of hereditary haemorrhagic telangiectasia. Archives of Dermatology 107: 571.
    CrossrefPubMedGoogle Scholar
  • 16 Lendrum A. C, Fraser D. S, Slidders W, Henderson R. 1962; Studies on the character and staining of fibrin. Journal of Clinical Pathology 15: 401.
    CrossrefPubMedGoogle Scholar
  • 17 Markwardt F, Klöcking H. P. 1976; Studies on the release of plasminogen activator. Thrombosis Research 8: 217.
    PubMedGoogle Scholar
  • 18 Mishchenko V. P, Kuznik B. I, Bochkarnikov V. V. 1972; The mechanism of action of vasoactive agents on the blood clotting and fibrinolysis. Cor Vasa 14: 228.
    PubMedGoogle Scholar
  • 19 Noordhoek Hegt V, Brakman P. 1974; a Histochemical study of an inhibitor of fibrinolysis in the human arterial wall. Nature (London) 248: 75.
    CrossrefPubMedGoogle Scholar
  • 20 Noordhoek Hegt V, Brakman P. 1974; b Inhibition of fibrinolysis by the human vascular wall related to smooth muscles. Circulation (Supplement III) 50: 296.
    PubMedGoogle Scholar
  • 21 Noordhoek Hegt V, Brakman P. 1974; c Inhibition of fibrinolysis by the human vascular wall related to the presence of smooth muscle cells. Haemostasis 3: 118.
    PubMedGoogle Scholar
  • 22 Noordhoek Hegt V. 1975; Endothelial and smooth muscle cells as antagonists in vascular fibrinolysis. Thrombosis et Diathesis Haemorrhagica 34: 608 (Abstr).
    PubMedGoogle Scholar
  • 23 Noordhoek Hegt V. 1976; Distribution and variation of fibrinolytic activity in the walls of human arteries and veins. Haemostasis 5: 355.
    PubMedGoogle Scholar
  • 24 Noordhoek Hegt V. 1977; Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins. Thrombosis Research 10: 121.
    CrossrefPubMedGoogle Scholar
  • 25 Ooneda G, Yoshida Y, Suzuki K, Sekiguchi T. 1973; Morphogenesis of plasmatic arterionecrosis as the cause of hypertensive intracerebral hemorrhage. Virchows Archiv (Abteilung) A: Pathologische Anatomie 361: 31.
    PubMedGoogle Scholar
  • 26 Pandolfi M, Robertson B, Isacson S, Nilsson I. M. 1968; Fibrinolytic activity of human veins in arms and legs. Thrombosis et Diathesis Haemorrhagica 20: 247.
    PubMedGoogle Scholar
  • 27 Pandolfi M. 1970; Persistence of fibrinolytic activity in fragments of human veins cultured in vitro. Thrombosis et Diathesis Haemorrhagica 24: 43.
    PubMedGoogle Scholar
  • 28 Pugatch E. M. J, Foster E. A, MacFarlane D. E, Poole J. C. F. 1970; The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mesothelium. British Journal of Haematology 18: 669.
    CrossrefPubMedGoogle Scholar
  • 29 Todd A. S. 1959; The histological localization of fibrinolysin activator. Journal of Pathology and Bacteriology 78: 281.
    CrossrefPubMedGoogle Scholar
  • 30 Todd A. S. 1960. The tissue activator of plasminogen and thrombosis. In: Walker W. (ed.) Thrombosis and Anticoagulant Therapy.. London: Livingstone Ltd.; 25.
    Google Scholar
  • 31 Todd A. S, Hargreaves L.N. McF. 1975. Identification of plasminogen activator in tissue. In: Davidson J. F, Samama M. M, Desnoyers P. C. (eds.). Progress in Chemical Fibrinolysis and Thrombolysis. Vol. I. Raven Press; New York.: 217.
    Google Scholar